Nuclear protein IκB-ζ inhibits the activity of STAT3

Biochemical and Biophysical Research Communications

Volumn 387, Issue 2, 2009, Pages 348-352

  Wu, Zhihao ^a   Zhang, Xiaoai ^a   Yang, Juntao ^a   Wu, Guangzhou ^a   Zhang, Ying ^a   Yuan, Yanzhi ^a   Jin, Chaozhi ^a   Chang, Zhijie ^c   Wang, Jian ^a   Yang, Xiaoming ^a   He, Fuchu ^a,b  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

^c TSINGHUA UNIVERSITY   (China)

Author keywords

Apoptosis; I B ; Inhibition; STAT3; Transcription

Indexed keywords

I KAPPA B; I KAPPA B ZETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; NFKBIZ PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN BCL 2; STAT3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION; TWO HYBRID SYSTEM; CELL LINE; CELL NUCLEUS; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

APOPTOSIS; CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; HUMANS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 67949110955     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.023     Document Type: Article

References (33)

1. Takeda K., and Akira S. Multi-functional roles of Stat3 revealed by conditional gene targeting. Arch. Immunol. Ther. Exp. (Warsz) 49 (2001) 279-283
2. Hodge D.R., Hurt E.M., and Farrar W.L. The role of IL-6 and STAT3 in inflammation and cancer. Eur. J. Cancer 41 (2005) 2502-2512
3. Itoh S., Udagawa N., Takahashi N., Yoshitake F., Narita H., Ebisu S., and Ishihara K. A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Bone 39 (2006) 505-512
4. Rubin Grandis J., Zeng Q., and Drenning S.D. Epidermal growth factor receptor-mediated stat3 signaling blocks apoptosis in head and neck cancer. Laryngoscope 110 (2000) 868-874
5. Turkson J., Bowman T., Garcia R., Caldenhoven E., De Groot R.P., and Jove R. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18 (1998) 2545-2552
6. Hirano T., Ishihara K., and Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19 (2000) 2548-2556
7. Klampfer L. The role of signal transducers and activators of transcription in colon cancer. Front. Biosci. 13 (2008) 2888-2899
8. Kanda N., Seno H., Konda Y., Marusawa H., Kanai M., Nakajima T., Kawashima T., Nanakin A., Sawabu T., Uenoyama Y., Sekikawa A., Kawada M., Suzuki K., Kayahara T., Fukui H., Sawada M., and Chiba T. STAT3 is constitutively activated and supports cell survival in association with surviving expression in gastric cancer cells. Oncogene 23 (2004) 4921-4929
9. Pedranzini L., Leitch A., and Bromberg J. Stat3 is required for the development of skin cancer. J. Clin. Invest. 114 (2004) 619-622
10. Xu D., and Qu C.K. Protein tyrosine phosphatases in the JAK/STAT pathway. Front. Biosci. 13 (2008) 4925-4932
11. Shuai K. Regulation of cytokine signaling pathways by PIAS proteins. Cell Res. 16 (2006) 196-202
12. Cooney R.N. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock 17 (2002) 83-90
13. Perry E., Tsruya R., Levitsky P., Pomp O., Taller M., Weisberg S., Parris W., Kulkarni S., Malovani H., Pawson T., Shpungin S., and Nir U. TMF/ARA160 is a BC-box-containing protein that mediates the degradation of Stat3. Oncogene 23 (2004) 8908-8919
14. Yuan Z.L., Guan Y.J., Chatterjee D., and Chin Y.E. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 307 (2005) 269-273
15. Lufei C., Ma J., Huang G., Zhang T., Novotny-Diermayr V., Ong C.T., and Cao X. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J. 22 (2003) 1325-1335
16. Rong Y., Cheng L., Ning H., Zou J., Zhang Y., Xu F., Liu L., Chang Z., and Fu X.Y. Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor. Cancer Res. 66 (2006) 8049-8057
17. Ohbayashi N., Taira N., Kawakami S., Togi S., Sato N., Ikeda O., Kamitani S., Muromoto R., Sekine Y., and Matsuda T. An RNA biding protein, Y14 interacts with and modulates STAT3 activation. Biochem. Biophys. Res. Commun. 372 (2008) 475-479
18. Tsuruma R., Ohbayashi N., Kamitani S., Ikeda O., Sato N., Muromoto R., Sekine Y., Oritani K., and Matsuda T. Physical and functional interactions between STAT3 and KAP1. Oncogene 27 (2008) 3054-3059
19. Totzke G., Essmann F., Pohlmann S., Lindenblatt C., Janicke R.U., and Schulze-Osthoff K. A novel member of the IkappaB family, human IkappaB-zeta, inhibits transactivation of p65 and its DNA binding. J. Biol. Chem. 281 (2006) 12645-12654
20. Yamazaki S., Muta T., and Takeshige K. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J. Biol. Chem. 276 (2001) 27657-27662
21. Ueta M., Hamuro J., Yamamoto M., Kaseda K., Akira S., and Kinoshita S. Spontaneous ocular surface inflammation and goblet cell disappearance in I kappa B zeta gene-disrupted mice. Invest. Ophthalmol. Vis. Sci. 46 (2005) 579-588
22. Hung W., and Elliott B. Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells. J. Biol. Chem. 276 (2001) 12395-12403
23. Liu H., Ma Y., Cole S.M., Zander C., Chen K.H., Karras J., and Pope R.M. Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival. Blood 102 (2003) 344-352
24. Goetz C.A., and Baldwin A.S. NF-kappaB pathways in the immune system: control of the germinal center reaction. Immunol. Res. 41 (2008) 233-247
25. Ivashkiv L.B. Jak-STAT signaling pathways in cells of the immune system. Rev. Immunogenet. 2 (2000) 220-230
26. Kamakura S., Oishi K., Yoshimatsu T., Nakafuku M., Masuyama N., and Gotoh Y. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat. Cell Biol. 6 (2004) 547-554
27. Hu X., Chen J., Wang L., and Ivashkiv L.B. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J. Leukoc. Biol. 82 (2007) 237-243
28. Albrecht U., Yang X., Asselta R., Keitel V., Tenchini M.L., Ludwig S., Heinrich P.C., Haussinger D., Schaper F., and Bode J.G. Activation of NF-kappaB by IL-1beta blocks IL-6-induced sustained STAT3 activation and STAT3-dependent gene expression of the human gamma-fibrinogen gene. Cell. Signal. 19 (2007) 1866-1878
29. Liu B., Yang R., Wong K.A., Getman C., Stein N., Teitell M.A., Cheng G., Wu H., and Shuai K. Negative regulation of NF-kappaB signaling by PIAS1. Mol. Cell. Biol. 25 (2005) 1113-1123
30. Mabb A.M., Wuerzberger-Davis S.M., and Miyamoto S. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat. Cell Biol. 8 (2006) 986-993
31. Wang Y., Wu T.R., Cai S., Welte T., and Chin Y.E. Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation. Mol. Cell. Biol. 20 (2000) 4505-4512
32. Hayden M.S., and Ghosh S. Shared principles in NF-kappaB signaling. Cell 132 (2008) 344-362
33. Kwon M.C., Koo B.K., Moon J.S., Kim Y.Y., Park K.C., Kim N.S., Kwon M.Y., Kong M.P., Yoon K.J., Im S.K., Ghim J., Han Y.M., Jang S.K., Shong M., and Kong Y.Y. Crif1 is a novel transcriptional coactivator of STAT3. EMBO J. 27 (2008) 642-653